OIM
TEVA icon

Orca Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Orca Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-35,180
Closed -$1.89M – 86
2014
Q3 		$1.89M Sell
35,180
-2,545
-7% -$135K 1.63% 20
2014
Q2 		$1.98M Sell
37,725
-1,375
-4% -$70.3K 1.56% 25
2014
Q1 		$2.07M Sell
39,100
-390
-1% -$18K 1.72% 23
2013
Q4 		$1.58M Buy
+39,490
New +$1.55M 1.29% 30

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Orca Investment Management's TEVA Position: Q4 2014 in Review

Orca Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2014, closing a stake of 35,180 shares — an estimated $1.89M sold.

Orca Investment Management first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $2.07M in Q1 2014. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • Orca Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Orca Investment Management sold 35,180 Teva Pharmaceuticals shares in Q4 2014, an estimated $1.89M.
  • Orca Investment Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 4 quarters.
  • Orca Investment Management's Teva Pharmaceuticals position peaked at $2.07M in Q1 2014.
  • 821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Orca Investment Management's 13F filing for Q4 2014, filed 27 Jan 2015.